MGRX: Mangoceuticals, Inc. - Summary | Jitta

Mangoceuticals, Inc.

NASDAQ:MGRX

Price
$0.45
Loss Chance
57.9%
1.15JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
3,628 / 4,217
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (17)
Recent Business Performance (28)
Financial Strength (50)
Return to Shareholders (0)
Competitive Advantage (12)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Operating MarginDeclined
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.15
100.00%
4.24
104.29%
Drug Retail
2.82
564.09%
COMPANY DESCRIPTION
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.